別名

Captopril - CAS 62571-86-2 - Calbiochem,[2S]-1-[3-Mercapto-2-methylpropionyl]-L-proline, SQ-14225

一般描述

An antihypertensive agent that competitively inhibits angiotensin-converting enzyme (ACE; IC50= 23-35 nM) and acts as a reversible and competitive inhibitor of LTA4 hydrolase (IC50 = 11 μM). Inhibits angiogenesis and slows the growth of experimental tumors in rats. Reported to inhibit apoptosis in human lung epithelial cells (IC50 = ~ 320 nM). An antihypertensive agent. Reversible and competitive inhibitor of LTA4 hydrolase (IC50 = 11 μM). Also a competitive inhibitor of angiotensin-converting enzyme (ACE). Inhibits angiogenesis and slows the growth of experimental tumors in rats.

生化/生理作用

Cell permeable: no Primary Target
ACE Product does not compete with ATP. Reversible: yes Target IC50: 23-35 nM against angiotensin-converting enzyme (ACE); 11 μM against LTA4 hydrolase; ~ 320 nM inhibiting apoptosis in human lung epithelial cells

其他說明

Uhal, B.D., et al. 1998. Am. J. Physiol.275, L1013.
Volpert, O.V., et al. 1996. J. Clin. Invest.98, 671.
Voors, A.A., et al. 1995. J. Cardiovasc. Risk2, 413.
Orning, L., et al. 1991. J. Biol. Chem. 266, 16507.
Kostis, J. 1988. Am. Heart J. 116, 1591.